table of content
1 Parenteral Drugs Market Overview
1.1 Product Overview and Scope of Parenteral Drugs
1.2 Parenteral Drugs Segment by Type
1.2.1 Global Parenteral Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Parenteral Drugs Segment by Application
1.3.1 Global Parenteral Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Global Parenteral Drugs Market Size Estimates and Forecasts
1.4.1 Global Parenteral Drugs Revenue 2017-2028
1.4.2 Global Parenteral Drugs Sales 2017-2028
1.4.3 Parenteral Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Parenteral Drugs Market Competition by Manufacturers
2.1 Global Parenteral Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Parenteral Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Parenteral Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Parenteral Drugs Manufacturing Sites, Area Served, Product Type
2.5 Parenteral Drugs Market Competitive Situation and Trends
2.5.1 Parenteral Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Parenteral Drugs Players Market Share by Revenue
2.5.3 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parenteral Drugs Retrospective Market Scenario by Region
3.1 Global Parenteral Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Parenteral Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Parenteral Drugs Market Facts & Figures by Country
3.3.1 North America Parenteral Drugs Sales by Country
3.3.2 North America Parenteral Drugs Revenue by Country
3.3.3 United States
3.3.4 Canada
3.3.3 Mexico
3.4 Europe Parenteral Drugs Market Facts & Figures by Country
3.4.1 Europe Parenteral Drugs Sales by Country
3.4.2 Europe Parenteral Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parenteral Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Parenteral Drugs Sales by Region
3.5.2 Asia Pacific Parenteral Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parenteral Drugs Market Facts & Figures by Country
3.6.1 Latin America Parenteral Drugs Sales by Country
3.6.2 Latin America Parenteral Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Parenteral Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Parenteral Drugs Sales by Country
3.7.2 Middle East and Africa Parenteral Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Parenteral Drugs Historic Market Analysis by Type
4.1 Global Parenteral Drugs Sales Market Share by Type (2017-2022)
4.2 Global Parenteral Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Parenteral Drugs Price by Type (2017-2022)
5 Global Parenteral Drugs Historic Market Analysis by Application
5.1 Global Parenteral Drugs Sales Market Share by Application (2017-2022)
5.2 Global Parenteral Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Parenteral Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Ostuka Pharmaceutical
6.1.1 Ostuka Pharmaceutical Corporation Information
6.1.2 Ostuka Pharmaceutical Description and Business Overview
6.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Ostuka Pharmaceutical Parenteral Drugs Product Portfolio
6.1.5 Ostuka Pharmaceutical Recent Developments/Updates
6.2 Teva Pharmaceutical Industries
6.2.1 Teva Pharmaceutical Industries Corporation Information
6.2.2 Teva Pharmaceutical Industries Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio
6.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.3 Kelun Pharma
6.3.1 Kelun Pharma Corporation Information
6.3.2 Kelun Pharma Description and Business Overview
6.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Kelun Pharma Parenteral Drugs Product Portfolio
6.3.5 Kelun Pharma Recent Developments/Updates
6.4 Cook Pharmica
6.4.1 Cook Pharmica Corporation Information
6.4.2 Cook Pharmica Description and Business Overview
6.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Cook Pharmica Parenteral Drugs Product Portfolio
6.4.5 Cook Pharmica Recent Developments/Updates
6.5 Patheon
6.5.1 Patheon Corporation Information
6.5.2 Patheon Description and Business Overview
6.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Patheon Parenteral Drugs Product Portfolio
6.5.5 Patheon Recent Developments/Updates
6.6 BAG Healthcare
6.6.1 BAG Healthcare Corporation Information
6.6.2 BAG Healthcare Description and Business Overview
6.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 BAG Healthcare Parenteral Drugs Product Portfolio
6.6.5 BAG Healthcare Recent Developments/Updates
6.7 Beximco Pharma
6.6.1 Beximco Pharma Corporation Information
6.6.2 Beximco Pharma Description and Business Overview
6.6.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Beximco Pharma Parenteral Drugs Product Portfolio
6.7.5 Beximco Pharma Recent Developments/Updates
6.8 Baxter Healthcare Corporation
6.8.1 Baxter Healthcare Corporation Corporation Information
6.8.2 Baxter Healthcare Corporation Description and Business Overview
6.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Baxter Healthcare Corporation Parenteral Drugs Product Portfolio
6.8.5 Baxter Healthcare Corporation Recent Developments/Updates
6.9 B. Braun
6.9.1 B. Braun Corporation Information
6.9.2 B. Braun Description and Business Overview
6.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 B. Braun Parenteral Drugs Product Portfolio
6.9.5 B. Braun Recent Developments/Updates
6.10 Fresenius
6.10.1 Fresenius Corporation Information
6.10.2 Fresenius Description and Business Overview
6.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Fresenius Parenteral Drugs Product Portfolio
6.10.5 Fresenius Recent Developments/Updates
6.11 Albert David
6.11.1 Albert David Corporation Information
6.11.2 Albert David Parenteral Drugs Description and Business Overview
6.11.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Albert David Parenteral Drugs Product Portfolio
6.11.5 Albert David Recent Developments/Updates
6.12 BML Parenteral Drugs
6.12.1 BML Parenteral Drugs Corporation Information
6.12.2 BML Parenteral Drugs Parenteral Drugs Description and Business Overview
6.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 BML Parenteral Drugs Parenteral Drugs Product Portfolio
6.12.5 BML Parenteral Drugs Recent Developments/Updates
6.13 Pfizer (Hospira)
6.13.1 Pfizer (Hospira) Corporation Information
6.13.2 Pfizer (Hospira) Parenteral Drugs Description and Business Overview
6.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Pfizer (Hospira) Parenteral Drugs Product Portfolio
6.13.5 Pfizer (Hospira) Recent Developments/Updates
6.14 Pisa
6.14.1 Pisa Corporation Information
6.14.2 Pisa Parenteral Drugs Description and Business Overview
6.14.3 Pisa Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Pisa Parenteral Drugs Product Portfolio
6.14.5 Pisa Recent Developments/Updates
6.15 Ozon Pharmaceuticals Ltd
6.15.1 Ozon Pharmaceuticals Ltd Corporation Information
6.15.2 Ozon Pharmaceuticals Ltd Parenteral Drugs Description and Business Overview
6.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio
6.15.5 Ozon Pharmaceuticals Ltd Recent Developments/Updates
6.16 Aspen Holdings
6.16.1 Aspen Holdings Corporation Information
6.16.2 Aspen Holdings Parenteral Drugs Description and Business Overview
6.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Aspen Holdings Parenteral Drugs Product Portfolio
6.16.5 Aspen Holdings Recent Developments/Updates
6.17 PSI Ltd
6.17.1 PSI Ltd Corporation Information
6.17.2 PSI Ltd Parenteral Drugs Description and Business Overview
6.17.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 PSI Ltd Parenteral Drugs Product Portfolio
6.17.5 PSI Ltd Recent Developments/Updates
6.18 Wintac Limited
6.18.1 Wintac Limited Corporation Information
6.18.2 Wintac Limited Parenteral Drugs Description and Business Overview
6.18.3 Wintac Limited Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Wintac Limited Parenteral Drugs Product Portfolio
6.18.5 Wintac Limited Recent Developments/Updates
6.19 AXA Parenterals Ltd
6.19.1 AXA Parenterals Ltd Corporation Information
6.19.2 AXA Parenterals Ltd Parenteral Drugs Description and Business Overview
6.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.19.4 AXA Parenterals Ltd Parenteral Drugs Product Portfolio
6.19.5 AXA Parenterals Ltd Recent Developments/Updates
6.20 Acebright
6.20.1 Acebright Corporation Information
6.20.2 Acebright Parenteral Drugs Description and Business Overview
6.20.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Acebright Parenteral Drugs Product Portfolio
6.20.5 Acebright Recent Developments/Updates
6.21 Southwest Pharmaceutical
6.21.1 Southwest Pharmaceutical Corporation Information
6.21.2 Southwest Pharmaceutical Parenteral Drugs Description and Business Overview
6.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Southwest Pharmaceutical Parenteral Drugs Product Portfolio
6.21.5 Southwest Pharmaceutical Recent Developments/Updates
6.22 Abbott
6.22.1 Abbott Corporation Information
6.22.2 Abbott Parenteral Drugs Description and Business Overview
6.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Abbott Parenteral Drugs Product Portfolio
6.22.5 Abbott Recent Developments/Updates
7 Parenteral Drugs Manufacturing Cost Analysis
7.1 Parenteral Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parenteral Drugs
7.4 Parenteral Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parenteral Drugs Distributors List
8.3 Parenteral Drugs Customers
9 Parenteral Drugs Market Dynamics
9.1 Parenteral Drugs Industry Trends
9.2 Parenteral Drugs Market Drivers
9.3 Parenteral Drugs Market Challenges
9.4 Parenteral Drugs Market Restraints
10 Global Market Forecast
10.1 Parenteral Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Parenteral Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Parenteral Drugs by Type (2023-2028)
10.2 Parenteral Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Parenteral Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Parenteral Drugs by Application (2023-2028)
10.3 Parenteral Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parenteral Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Parenteral Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
